Judith Prescott, DVM, PhD, DACVP

Dr. Prescott has over 25 years of experience in nonclinical drug discovery and development and is a board-certified veterinary clinical pathologist. She has held leadership positions at Merck and GSK with a demonstrated track record of accountability, commitment, and good decision making, and most recently was Associate Vice President and head of a global team responsible for the strategic and logistical oversight of all nonclinical discovery and development safety programs across the Merck portfolio.  This included oversight of programs in the Infectious Diseases, Oncology, Immunology, Cardiometabolic, Neurosciences, and Vaccine Therapeutic Areas and oversight of several product registrations for small molecules, biologics, and vaccines.  In addition to breadth and depth of experience in nonclinical toxicology and drug development from discovery through registration and life-cycle management, Dr. Prescott is experienced in the resolution of complex scientific and regulatory issues and development of global regulatory strategies.